Who is the manufacturer of Neodent Implant System - GM Helix Implants 7.0?

Jjgc Industria E Comercio DE Materiais Dentarios S.A. filed the 510(k) submission for Neodent Implant System - GM Helix Implants 7.0 (K201225).

What is the FDA product code for Neodent Implant System - GM Helix Implants 7.0?

DZE. It is classified under 21 CFR 872.3640 as a Class 2 device in the Dental panel.

What is the regulatory pathway for Neodent Implant System - GM Helix Implants 7.0?

510(k) clearance (submission type: Traditional).

What are the predicate devices for Neodent Implant System - GM Helix Implants 7.0?

Neodent Implant System – GM Line (K163194).

Who can help prepare an FDA 510(k) submission like Neodent Implant System - GM Helix Implants 7.0?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

Neodent Implant System - GM Helix Implants 7.0

K201225 · Jjgc Industria E Comercio DE Materiais Dentarios S.A. · DZE · Sep 4, 2020 · Dental

Device Facts

Record ID	K201225
Device Name	Neodent Implant System - GM Helix Implants 7.0
Applicant	Jjgc Industria E Comercio DE Materiais Dentarios S.A.
Product Code	DZE · Dental
Decision Date	Sep 4, 2020
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 872.3640
Device Class	Class 2
Attributes	Therapeutic

Intended Use

The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices, such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading.

Device Story

Neodent Implant System - GM Helix Implants 7.0 are endosseous dental implants; surgically placed in upper or lower jaw bone to support prosthetic devices (artificial teeth) for chewing function restoration. Implants feature conical body/apex, rounded apex, and trapezoidal-profile double threads; manufactured from commercially pure titanium (Grade 4). Provided sterile via gamma irradiation for single use. Operated by dental surgeons in clinical settings. Output is a stable base for prosthetic abutments. Clinical benefit includes restoration of oral function and aesthetics. Device integrates with existing Neodent GM line abutments.

Clinical Evidence

Bench testing only. Biocompatibility assessed per ISO 10993-1, -5, -12, and -18. Mechanical performance validated via dynamic fatigue testing per ISO 14801. Sterilization validated per ISO 11137-1/2 (SAL 10^-6). Shelf life validated via accelerated aging (ASTM F1980) and packaging integrity tests (ASTM F88, F1929, F2096). Endotoxin testing performed per USP <161>.

Technological Characteristics

Material: Commercially pure titanium Grade 4 (ASTM F67). Design: Conical body/apex, rounded apex, trapezoidal double threads. Interface: Morse Taper with internal hexagonal indexer (GM line). Dimensions: 7.0mm diameter; 8-13mm lengths. Sterilization: Gamma irradiation (25 kGy). Single-use, non-reusable.

Indications for Use

Indicated for patients requiring dental restoration in the upper or lower jaw; supports single or multiple unit prosthetic devices; suitable for single-stage or two-stage surgical procedures; allows for immediate loading given sufficient primary stability and appropriate occlusal loading.

Regulatory Classification

Identification

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

Special Controls

*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

Predicate Devices

Neodent Implant System – GM Line (K163194)

Reference Devices

Neodent Implant System – GM Line (K180536)
KAT Implant System (K101201)
Legacy4 (K192221)
Legacy2, SimplyLegacy2, Legacy3, SimplyLegacy3, Legacy4 Dental Implants (K192221)
Legacy2, Legacy3, Legacy4 Fixture-Mounts (K192221)
MRI Compatibility For Existing Neodent Implant System (K182620)
Neodent Implant System - Change in the Shelf Life of Neodent Acqua Implants (K193592)

Related Devices

K190958 — Neodent Implant System · Jjgc Industria E Comercio DE Materiais Dentarios S.A. · Nov 9, 2019
K203382 — Neodent Implant System-Easy Pack · Jjgc Industria E Comercio DE Materiais Dentarios S.A. · Mar 15, 2021
K223638 — Neodent Implant System - Helix Short Implant System · Jjgc Industria E Comercio DE Materiais Dentarios S.A. · Jun 23, 2023
K221847 — Ni2 Implant System · Newton Implant Systems, Inc. · Apr 11, 2024
K061500 — SICACE DENTAL IMPLANT SYSTEM AND SIC ANGLED ABUTMENTS · Sic Invent AG · Aug 8, 2006

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. September 4, 2020 JJGC Indústria e Comércio de Materiais Dentários S.A. % Jennifer Jackson Director of Regulatory Affairs Straumann USA, LLC 60 Minuteman Road Andover, Massachusetts 01810 Re: K201225 Trade/Device Name: Neodent Implant System - GM Helix Implants 7.0 Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE Dated: June 12, 2020 Received: June 15, 2020 Dear Jennifer Jackson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or post-marketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. for Srinivas Nandkumar, Ph.D. Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known) K201225 Device Name Neodent Implant System - GM Helix Implants 7.0 Indications for Use (Describe) The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices, such as artificial teeth, to restore chewing function. It may be used with single-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. Type of Use (Select one or both, as applicable) Prescription Use (21 CFR Part 801 Subpart D) □ Over-The-Counter Use (21 CFR 801 Subpart C) ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff @fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # 510(k) Summary # ADMINISTRATIVE INFORMATION | Sponsor | JJGC Indústria e Comércio de Materiais Dentários SA (dba Neodent) Av. Juscelino Kubitschek de Oliveira, 3291 Curitiba, Parana, Brazil 81270-200 Registration No.: 3008261720 Owner/Operator No.: 10031702 | |--------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Contact Person | Jennifer M. Jackson, MS Director of Regulatory Affairs, Straumann USA E-mail: jennifer.jackson@straumann.com Telephone (978) 747-2509 | | Date Prepared | 03/Sep/2020 | | Preparer / Alternate Contact | Mariana Soares Hartmann Regulatory Affairs Analyst E-mail: mariana.hartmann@neodent.com | | DEVICE NAME AND CLASSIFICATION | | | Trade/ Proprietary Name Common Name | Neodent Implant System - GM Helix Implants 7.0 Endosseous dental implant | | Classification Name | Endosseous dental implant | | Classification Regulations Product Code | 21 CFR 872.3640, Class II DZE | | Classification Panel Reviewing Branch | Dental Products Panel Dental Devices Branch | | PREDICATE DEVICE INFORMATION | | | Primary Predicate Device | K163194, Neodent Implant System – GM Line, JJGC Indústria e Comércio de Materiais Dentários S.A | | Reference Predicate Devices | K180536, Neodent Implant System – GM Line, JJGC Indústria e Comércio de Materiais Dentários S.A K101201, KAT Implant System - KAT Implants LLC | {4}------------------------------------------------ Legacy2, SimplyLegacy2, K192221, Legacy3, Legacy4, SimplyLegacy3 Dental Implants; Legacy2, Legacy3, Legacy4 Fixture-Mounts, Implant Direct Sybron Manufacturing, LLC K182620 - MRI Compatibility For Existing Neodent Implant System, JJGC Indústria e Comércio de Materiais Dentários S.A K193592 - Neodent Implant System - Change in the Shelf Life of Neodent Acqua Implants ### INDICATIONS FOR USE The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices, such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. ### SUBJECT DEVICE DESCRIPTIONS - Intended for single use; - . Provided sterile via gamma irradiation; - Manufactured of commercially pure titanium (Ti) grade 4 per ASTM F67; - . Morse Taper prosthetic interface with internal hexagonal indexer, exclusively from the Grand Morse (GM) line; - . Body center and apex with conical format; - Trapezoidal-profile double threads; - Rounded apex end; - . Available in Neoporos and Acqua surfaces; - Ø7.0 mm and 8, 10, 11.5, and 13 mm lengths; - The subject devices are compatible with all the abutments of the Neodent Implant System that present the GM implant to abutment interface, previously cleared per K163194, K173902, K180536, K191191, and K1922229. {5}------------------------------------------------ # TECHNOLOGICAL CHARACTERISTIC COMPARISON TABLE | | SUBJECT DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE PREDICATE | | |------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | Neodent Implant System - GM Helix Implants 7.0 JJGC Indústria e Comércio de Materiais Dentários S.A. | K163194 Neodent Implant System - GM Line JJGC Indústria e Comércio de Materiais Dentários S.A. | K101201 KAT Implant System KAT Implants LLC | K192221 Legacy4 Implant Direct Sybron Manufacturing LLC | | Indications for Use | The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices, such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. | The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices, such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. | KAT Implant System Dental Implants are indicated for restoration of edentulous maxilla and mandible, to provide support for removable dentures, fixed bridges, or to be used as a single tooth replacement. Single or splinted implants can be immediately loaded if good primary stability and appropriate occlusal loading is achieved. The implants can be placed in extraction sites or healed alveolar ridges. Immediate loading may not be appropriate in Type IV bone due to difficulty in achieving primary stability. | Legacy2, simplyLegacy2, Legacy3, simplyLegacy3, and Legacy4 dental implants are two-piece implants for one- stage or two-stage surgical procedures. These implants are intended for use in partially and fully edentulous upper and lower jaws in support of single or multiple- unit restorations and terminal or intermediate abutment support for fixed bridgework. Implants can be indicated for immediate loading when good primary stability has been achieved and with appropriate occlusal loading. Narrow (3.2mmD) implants: Indicated for single-tooth replacement (mandibular central and lateral incisors; maxillary lateral incisors), multiple-tooth replacements or denture stabilization. Short (<10mm) 3.7mm implants: Indicated for single-tooth (mandibular and maxillary central and lateral incisors), multiple tooth replacements or denture stabilization. The Legacy 2, Legacy3, and Legacy4 fixture- mounts are intended for use | {6}------------------------------------------------ | | SUBJECT DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE PREDICATE | | | | | | | | |-----------------------------------|---------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--|--|--|--|--| | | Neodent Implant System - GM Helix Implants 7.0 JJGC Indústria e Comércio de Materiais Dentários S.A. | K163194 Neodent Implant System - GM Line JJGC Indústria e Comércio de Materiais Dentários S.A. | K101201 KAT Implant System KAT Implants LLC | K192221 Legacy4 Implant Direct Sybron Manufacturing LLC with the corresponding dental implants (Legacy2, Legacy3, and Legacy4, respectively). The fixture-mounts can function as an abutment. As an abutment, fixture-mounts are intended for use with dental implants in the maxillary and/or mandibular arches to provide support for crowns or bridges for edentulous or partially edentulous patients. Fixture-mounts as an abutment for narrow (3.2mmD) implants: Indicated for single- tooth replacement of mandibular central and lateral incisors and maxillary lateral incisors. Fixture-mounts as an abutment for short (8mm) 3.7mmD implants: Indicated for tooth replacement of mandibular and maxillary central and lateral incisors. Legacy2, simplyLegacy2, Legacy3, simplyLegacy3, and Legacy4 implants are compatible with the following abutments. Manufacturer Abutment Line Platform Diameter (mm) Implant Direct Legacy 3.0, 3.5, 4.5, 5.7 | | | | | | | | Implant- Abutment interface | GM | GM | 1.5° torque-activated locking taper connection | | | | | | | | | Design | Body center and apex with conical format Rounded apex Trapezoidal profile double threads | Body center and apex with conical format Rounded apex Trapezoidal profile double threads | Root-form implant; Endosseous screw type with a continuous thread and horizontal circumferential fins | Body and apex straight, lower portion tapered with progressively deeper buttress-threads | | | | | | | {7}------------------------------------------------ | | SUBJECT DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE PREDICATE | | |-------------------------|---------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------|---------------------------------------------------|---------------------------------------------------------------| | | Neodent Implant System - GM Helix Implants 7.0 JJGC Indústria e Comércio de Materiais Dentários S.A. | K163194 Neodent Implant System - GM Line JJGC Indústria e Comércio de Materiais Dentários S.A. | K101201 KAT Implant System KAT Implants LLC | K192221 Legacy4 Implant Direct Sybron Manufacturing LLC | | Reusable | No | No | No | No | | Length (mm) | 8; 10; 11.5; 13 | 8; 10; 11.5; 13; 16; 18 | 6; 8; 10 | 6; 8; 10; 11.5; 13; 16 | | Diameter (Ø) (mm) | 7.0 | 3.5; 3.75; 4.0; 4.3; 5.0 | 6.0; 7.0. 8.0 | 3.2; 3.7; 4.2; 4.7; 5.2; 5.7; 7.0 | | Material | Commercially pure Titanium grade 4 (ASTM F67) | Commercially pure Titanium grade 4 (ASTM F67) | Titanium alloy (ASTM F136) | Titanium alloy | | Sterilization Method | Gamma irradiation to a SAL of 1x10-6 | Gamma irradiation to a SAL of 1x10-6 | Gamma irradiation to a SAL of 1x10-6 | Gamma irradiation | The subject devices and the primary predicate device K163194 have the same design, similar range of lengths, same raw material and same sterlization method. The subject devices is within the range of the reference predicate devices (K101201). The subject devices and reference predicate devices (K101201 and K192221) are indicated for immediate loading when good primary stability has been achieved and with appropriate occlusal loading. {8}------------------------------------------------ ## PERFORMANCE DATA ### Biocompatibility Biocompatibility sample preparation was made according to ISO 10993-12. Biological Safety Assessment guided by ISO 10993-1, Cytotoxicity testing was performed per ISO 10993-5 and Chemical characterization was performed per ISO 10993-18. The subject implants are made of unalloyed titanium, Grade 4, conforming to ASTM F67 Standard Specification for Unalloyed Titanium for Surgical Implant Applications (UNS R50250, UNS R50400, UNS R50550, UNS R50700), the same type of titanium used for fabrication of the predicate devices cleared under K163194 and K180536. The subject devices undergo to the same manufacturing processes to the cited predicate devices. The subject devices do not present a new worst case for biocompatibility and therefore, the predicate and reference device testing are relied upon for determining substantial equivalence. ### Mechanical testing Dynamic fatigue test per ISO 14801 was performed to determine the fatigue strength for the dental implant system, according to FDA Guidance. The tested subject devices exhibit a level of performance equivalent to that reviewed for the predicate devices. Insertion torque testing was also performed to determine insertion torque for the dental implants in Type III and Type IV bone. ## Sterilization Validation The subject implants are sterilized by ℃o gamma irradiation at a nominal dose of 25 kGy (2.5 Mrad). Sterilization has been validated by the VDma22 method, according to ISO 11137-1 and ISO 11137-2. The method achieved a Sterility Assurance Level 10-6. The Subject devices are not represented to be "pyrogen free". Routine endotoxin testing for NeoPoros and Acqua implants are performed monthly on representative samples of this group of products. The test limit is 20 EU/device as recommended by USP <161>. The sterilization method presented for the subject devices is the same as for the predicate devices and has been previously reviewed under K163194 and K180536. ## Shelf Life Validation The subject implants have a shelf life of 5 years that was validated by accelerated aging according to ASTM F1980. The packaging was validated according to ISO 11607-1 and ISTA 2A. Sealing strength (ASTM F88), Dye Penetration (ASTM F1929), and Bubble Test (ASTM F2096) were conducted to verify the maintenance of the sterile barrier after storage. ## CONCLUSION The subject devices and the primary predicate devices K163194 have the same intended use, same design and technological characteristics, similar range of length, same sterilization method and are made of the same materials. The subject devices present a diameter that is contained within the range of diameters of the reference predicate devices. The data included in this submission demonstrate that the subject devices are substantially equivalent to the predicate devices.